Recruiting
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
NCT06629584
- Conditions
- Malignant Solid Tumors
- Locations
-
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States